What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Chemotherapy
Sydney E. Salmon mainly focuses on Internal medicine, Chemotherapy, Oncology, Multiple myeloma and Vincristine.
His Internal medicine research incorporates themes from Gastroenterology, Myeloma cast nephropathy and Surgery.
His work deals with themes such as Clinical research and Immunology, which intersect with Chemotherapy.
His studies deal with areas such as Putrescine, Predictive value and Body surface area as well as Oncology.
His Multiple myeloma research is multidisciplinary, incorporating elements of Cancer research, Stage, Bone marrow, Pathology and Creatinine.
The study incorporates disciplines such as Melphalan and Doxorubicin in addition to Vincristine.
His most cited work include:
- A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. (2518 citations)
- A new type of synthetic peptide library for identifying ligand-binding activity (1864 citations)
- Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. (1310 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Oncology, Pharmacology, Chemotherapy and Cancer research.
His work in Internal medicine tackles topics such as Gastroenterology which are related to areas like Adenocarcinoma.
He interconnects Clinical trial, Radiation therapy, Adjuvant therapy and Carcinoma in the investigation of issues within Oncology.
His Pharmacology research includes elements of Vinblastine, In vitro, Cytotoxicity and Doxorubicin.
His Chemotherapy study is associated with Surgery.
His Multiple myeloma research integrates issues from Bone marrow, Pathology and Prednisone.
He most often published in these fields:
- Internal medicine (34.09%)
- Oncology (23.18%)
- Pharmacology (18.18%)
What were the highlights of his more recent work (between 1994-2009)?
- Biochemistry (5.45%)
- Pharmacology (18.18%)
- Internal medicine (34.09%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Biochemistry, Pharmacology, Internal medicine, Peptide and Chemotherapy.
His Pharmacology research incorporates elements of Drug resistance, Immunology, Fetal bovine serum and Cytotoxicity.
Sydney E. Salmon undertakes multidisciplinary studies into Internal medicine and Verapamil in his work.
His Peptide study integrates concerns from other disciplines, such as Combinatorial chemistry, Anticancer drug and Drug discovery.
His Chemotherapy study is related to the wider topic of Surgery.
The Regimen study combines topics in areas such as Cyclophosphamide and Oncology.
Between 1994 and 2009, his most popular works were:
- Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. (1310 citations)
- Standard Chemotherapy Compared With High-Dose Chemoradiotherapy for Multiple Myeloma: Final Results of Phase III US Intergroup Trial S9321 (415 citations)
- Cytogenetics of 158 patients with regional or disseminated melanoma Subset analysis of near-diploid and simple karyotypes (128 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
His primary areas of investigation include Combinatorial chemistry, Cleavable linker, Pharmacology, Immunology and Cancer.
The concepts of his Combinatorial chemistry study are interwoven with issues in Cleavage and Peptide, Solid-phase synthesis, Peptide synthesis.
Chemotherapy is closely connected to Radiation therapy in his research, which is encompassed under the umbrella topic of Pharmacology.
His research integrates issues of Cisplatin, Blood proteins, IC50, Albumin and In vivo in his study of Immunology.
He has included themes like Carboplatin, Survival analysis, Nephrotoxicity and Nedaplatin in his Cancer study.
He is investigating Oncology and Internal medicine as part of his examination of Chemoradiotherapy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
